AnalystRadar
ACAD Updated Aug 14, 2026

ACADIA Pharmaceuticals Inc. (ACAD)

Analyst consensus, price target and coverage. 20 analysts, updated daily.

Consensus Buy= Unchanged
Price 28.38 USD
Mean target 33.50 USD
Upside +18.0% target vs price
Market cap Mid 4.9B

Analyst votes

How the ratings break down

21 ratings on record

Price targets

Where the estimates sit

How far apart analysts are on this name.

Low 17.00 Mean 33.50 High 45.00

share price 28.38 mean target 33.50. Analysts are spread 165% apart.

Most recent action

Last rating change

FirmNeedham
Date2026-08-12
ChangeBuy → Buy

Size and liquidity

Key statistics

Market cap4.89B USD
Cap classMid
Average volume1,629,743
Dollar volume per day46.3M
LiquidityHigh
Internal score72.1 / 100

Recommendation

How it moved, scan by scan

3 scans on record

ScanMoveConsensusScoreSBBuyHoldUndSell
2026-08-14 07:29 = Buy 2.14 4 12 4 0 1
2026-08-13 = Buy 2.14 4 12 4 0 1
2026-08-11 · Buy 2.14 4 12 4 0 1

Score is the analyst average on Yahoo's scale, where 1 is Strong Buy and 5 is Sell, so a falling number means the view improved. more positive, more negative, = unchanged.

History

Price target over time

3 daily points recorded

DatePriceTargetUpsideConsensus
2026-08-14 28.38 33.50 +18.0% Buy
2026-08-13 29.45 33.50 +13.8% Buy
2026-08-11 29.69 33.50 +12.8% Buy

Similar coverage

Comparable mid-cap names

Closest upside among companies of the same size.

← All 1035 companies in the screener